Envirotainer Grows Network Capabilities in Americas
Expansion is expected to meet the growing market demand from the region.
Envirotainer, a provider of secure cold-chain solutions for the air transportation of pharmaceuticals, has expanded its network capabilities in the Americas. The company has enhanced its operations and added more containers to handle the increasing volume of orders being shipped from the region.
The company claims that its branded RAP e2 containers are now able to make five times more one-way trips from the Americas to Asia-Pacific (APAC) compared to last year. Envirotainer also notes that it has seen a 65% increase in one-way capabilities for shipments of its RKN e1 containers.
“The expansion of our network underlines our commitment to the region,” notes Niklas Adamsson, Envirotainer’s COO. “By increasing our container capacity and enhancing our services, we’re ensuring life-saving medicines are available to patients where, and when, needed.”
Newsletter
Stay ahead in the life sciences industry with Pharmaceutical Commerce, the latest news, trends, and strategies in drug distribution, commercialization, and market access.
New UK Consortium Obtains $1.34M Grant to Launch Automated Cell Therapy Manufacturing Platform
July 15th 2025Cellular Origins, CGT Catapult, and Resolution Therapeutics partner up to design a fully automated, scalable CGT manufacturing solution, with the goal of accelerating patient access to cell therapies.
Study Connects COVID-19 Treatment Disparities to Gaps in Testing and Virtual Access
July 11th 2025New research finds that nearly half of the racial and ethnic disparities in outpatient COVID-19 antiviral prescriptions stem from encounter-level care barriers, such as limited access to rapid tests and telehealth, which emphasizes the need for systemic and practice-level reforms.
